The impact of South Korea's new drug-pricing policy on market competition among off-patent drugs.

about

Impact of price deregulation policy on the affordability of essential medicines for women's health: a panel data analysis.Drug Pricing in South Korea.

P2860

Q36371634-A732B67F-E21E-4758-BFD6-96BDA59417AE Q39110814-F85C315E-4FAA-40AA-A2C6-01738C6ACBCF

P2860

The impact of South Korea's new drug-pricing policy on market competition among off-patent drugs.

Item

http://www.wikidata.org/entity/Q40513945

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

The impact of South Korea's ne ...... tition among off-patent drugs.

@en

type

Item

label

The impact of South Korea's ne ...... tition among off-patent drugs.

@en

prefLabel

The impact of South Korea's ne ...... tition among off-patent drugs.

@en

P1476

The impact of South Korea's ne ...... tition among off-patent drugs.

@en

P2093

Hye-Young Kwon

http://www.w3.org/2001/XMLSchema#string

Hyungmin Kim

http://www.w3.org/2001/XMLSchema#string

Michael R Reich

http://www.w3.org/2001/XMLSchema#string

P2860

Are generic and brand-name statins clinically equivalent? Evidence from a real data-base.

Economic consequences of underuse of generic drugs: evidence from Medicaid and implications for prescription drug benefit plans.

The effect of generic competition on the price of brand-name drugs.

Clinical equivalence of generic and brand-name drugs used in cardiovascular disease: a systematic review and meta-analysis.

Multifaceted national and regional drug reforms and initiatives in ambulatory care in Sweden: global relevance.

Ongoing pharmaceutical reforms in France: implications for key stakeholder groups.

Reforms and initiatives in Scotland in recent years to encourage the prescribing of generic drugs, their influence and implications for other countries.

Ongoing measures to enhance the efficiency of prescribing of proton pump inhibitors and statins in The Netherlands: influence and future implications.

Impact of recent reforms in Austria on utilization and expenditure of PPIs and lipid-lowering drugs: implications for the future.

Potential savings in prescription drug costs for hypertension, hyperlipidemia, and diabetes mellitus by equivalent drug substitution in Austria: a nationwide cohort study.

P304

1007-1014

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1586/14737167.2015.1083425

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Brian Godman

P577

2015-09-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26394767

http://www.w3.org/2001/XMLSchema#string

The impact of South Korea's new drug-pricing policy on market competition among off-patent drugs.

about

P2860

P2860

The impact of South Korea's new drug-pricing policy on market competition among off-patent drugs.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698